AC
ALDR

Apex Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Apex Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$7.5M Buy
+227,200
New +$7.68M 0.8% 37

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Apex Capital's ALDR Position: Q4 2015 in Review

Apex Capital opened a new position in Alder Biopharmaceuticals (ALDR) in Q4 2015: 227,200 shares worth $7.5M. The stake represents 0.8% of the portfolio and ranks #37 among its holdings.

134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • Apex Capital held 227,200 shares of Alder Biopharmaceuticals worth $7.5M as of Q4 2015.
  • Alder Biopharmaceuticals was a new Apex Capital position in Q4 2015.
  • Alder Biopharmaceuticals made up 0.8% of Apex Capital's portfolio in Q4 2015, its #37 holding.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.